SCHEMBL25041352

SCHEMBL25041352

CC(C)(C)c1ccc(NC2CCC(N)CC2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.49
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
KDM1A O60341 3/20 0.36
MAOB P27338 1/20 0.36
ROCK1 Q13464 1/20 0.36
GAA P10253 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
MAPK14 Q16539 1/20 0.35
CSNK1D P48730 1/20 0.34
CSNK1G2 P78368 1/20 0.34
CDK7 P50613 2/20 0.34
CDK9 P50750 2/20 0.34
ALOX5AP P20292 1/20 0.34
KCNH2 Q12809 1/20 0.34
GRM2 Q14416 1/20 0.32
MELK Q14680 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25041354 0.85 ALDH1A1 (0.41) ROCK2PDE3BPDE3AKDM1AMAOB
SCHEMBL25041349 0.82 ROCK2 (0.37) ROCK2PDE3BPDE3AKDM1AMAOB
SCHEMBL19697061 0.82 PDE3B (0.37) ROCK2PDE3BPDE3AGAAMAPK8
SCHEMBL16285252 0.81 POLB (0.41) GAA
SCHEMBL25041348 0.79 CDK2 (0.38) ROCK2PDE3BPDE3ACSNK1DCSNK1G2
SCHEMBL30279117 0.79 CDK2 (0.38) ROCK2PDE3BPDE3ACSNK1DCSNK1G2
SCHEMBL19697059 0.78 HRH3 (0.41) KDM1AGAATRPV1
SCHEMBL19697056 0.76 EPHX2 (0.46)
SCHEMBL25040031 0.74 EPHX1 (0.42) KDM1AMAOBGAATRPV1
SCHEMBL25039545 0.74 EPHX1 (0.42) KDM1AMAOBGAATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 US disclosed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 EP disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 ROCK2 1973/4885PDE3B 3239/4885PDE3A 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.